Zdrowie i gospodarka · 24/10/2013

FDA Requests Public Comments on New Guidelines for Evaluating Clinical Trial Data to Inform Regulatory Decisions

The US Food and Drug Administration (FDA) is seeking public input on a new framework for conducting meta-analyses of randomized controlled clinical trials (RCTs) to assess the safety and efficacy of new treatments, with the goal of supporting regulatory decisions.